"
Comparison of Efficacy and Safety Evaluation of Latanoprost Formulations with and without Benzalkonium Chloride"
written by Hiroyoshi Kasai, Yumiko Aoyama, Takashi Kurasawa, Tomoyo Imamura, Kazuhiro Tsuruma, Hideaki Hara, Haruhisa Hirata, Tetsuya Yamamoto,
published by
Pharmacology & Pharmacy,
Vol.4 No.4, 2013
has been cited by the following article(s):
|
[1]
|
New Preservative-Free Formulation for the Enhanced Ocular Bioavailability of Prostaglandin Analogues in Glaucoma
Pharmaceutics,
2022
DOI:10.3390/pharmaceutics14020453
|
|
|
|
|
[2]
|
New Preservative-Free Formulation for the Enhanced Ocular Bioavailability of Prostaglandin Analogues in Glaucoma
Pharmaceutics,
2022
DOI:10.3390/pharmaceutics14020453
|
|
|
|
|
[3]
|
Intraocular Pressure Reduction Effect of 0.005% Latanoprost Eye Drops in a Hyaluronic Acid-Chitosan Nanoparticle Drug Delivery System in Albino Rabbits
Translational Vision Science & Technology,
2021
DOI:10.1167/tvst.10.4.2
|
|
|
|
|
[4]
|
Ophthalmic Product Development
AAPS Advances in the Pharmaceutical Sciences Series,
2021
DOI:10.1007/978-3-030-76367-1_20
|
|
|
|